AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Abattis Bioceuticals Corp.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
14.33K
AVG Volume
22.32K
Trailing/Forward PE
-0.01/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (CAD) · TTM
-100K0100K200K300K400K17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Revenue (CAD) · TTM by quarter
PeriodRevenue (CAD) · TTM
19 Q4356.88K
19 Q3133.08K
19 Q25.52K
19 Q19.01K
18 Q48.37K
18 Q35.9K
18 Q25.67K
18 Q10
17 Q40
17 Q3-54
Net Income (CAD) · TTM
-80M-60M-40M-20M017 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Net Income (CAD) · TTM by quarter
PeriodNet Income (CAD) · TTM
19 Q4-3.04M
19 Q3-56.33M
19 Q2-62.54M
19 Q1-74.05M
18 Q4-78.01M
18 Q3-27.58M
18 Q2-22.63M
18 Q1-11.85M
17 Q4-7.63M
17 Q3-4.69M
Operating Income (CAD) · TTM
-30M-20M-10M010M17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Operating Income (CAD) · TTM by quarter
PeriodOperating Income (CAD) · TTM
19 Q4-3.91M
19 Q33.99M
19 Q2-2.17M
19 Q1-12.77M
18 Q4-17.38M
18 Q3-27.09M
18 Q2-22.23M
18 Q1-11.54M
17 Q4-6.36M
17 Q3-4.84M
EBITDA (CAD) · TTM
-30M-20M-10M010M17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF EBITDA (CAD) · TTM by quarter
PeriodEBITDA (CAD) · TTM
19 Q4-2.9M
19 Q33.06M
19 Q2-1.19M
19 Q1-12.72M
18 Q4-17.34M
18 Q3-25.11M
18 Q2-22.15M
18 Q1-11.93M
17 Q4-6.71M
17 Q3-5.19M
Cash Flows (CAD) · TTM
-10M-5M05M17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Cash Flows (CAD) · TTM by quarter
PeriodCash Flows (CAD) · TTM
19 Q44.35M
19 Q33.96M
19 Q2-7.12M
19 Q1-6.95M
18 Q4-8.51M
18 Q3-7.4M
18 Q2-4.4M
18 Q1-4.48M
17 Q4-1.65M
17 Q3-1.33M
EPS (CAD) · TTM
-0.3-0.2-0.1-017 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF EPS (CAD) · TTM by quarter
PeriodEPS (CAD) · TTM
19 Q4-0.01
19 Q3-0.13
19 Q2-0.15
19 Q1-0.19
18 Q4-0.22
18 Q3-0.11
18 Q2-0.1
18 Q1-0.07
17 Q4-0.05
17 Q3-0.04
Expenses (CAD) · TTM
-10M010M20M30MR&DSG&ACapex17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Expenses (CAD) · TTM by quarter
PeriodExpenses (CAD) · TTM
19 Q49.21M
19 Q3-2.8M
19 Q21.37M
19 Q111.32M
18 Q416.03M
18 Q324.53M
18 Q221.98M
18 Q111.99M
17 Q46.67M
17 Q35.24M
Shares Outstanding (CAD) · TTM
-800K-600K-400K-200K0Buybacks (Repurchases)Stock-Based Compensation17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Shares Outstanding (CAD) · TTM by quarter
PeriodShares Outstanding (CAD) · TTM
19 Q4-1.62K
19 Q3-6.15K
19 Q2-23.72K
19 Q1-94.06K
18 Q4-494.81K
18 Q3-668.9K
18 Q2-651.34K
18 Q1-581K
17 Q4-718.65K
17 Q3-603.06K
Abattis Bioceuticals Corp.
ATTBF
Stockpicker

Video analysis: ATTBF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.